Organisation paid for research Program year 2025 Source: CMS Open Payments

Georgia Nephrology, LLC

Neither a doctor nor a teaching hospital

Research payments

$124,904

22 payments

Through program year 2025, Georgia Nephrology, LLC is reported as receiving $124,904 in research payments, across 22 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$16,498	1
2024	Research	$4,360	1
2023	Research	$21,224	1
2022	Research	$53,965	1
2019	Research	$28,857	18

Breakdown

Who paid Research payments · program years 2019–2025

Alexion Pharmaceuticals, Inc. $96,047 4 payments
Sanofi US Services Inc. $21,374 2 payments
EMD Serono, Inc. $7,483 16 payments

Studies the money was for Research payments · program years 2019–2025

A Phase 2, Double Blind, Randomized, Placebo Controlled Study of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) $96,047 4 payments
A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Sever $21,374 2 payments
Ms 700461-0035 $6,847 7 payments
Ms700461-0035 $636 9 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.